Equities

Butterfly Network Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
BFLY:NYQ

Butterfly Network Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)3.05
  • Today's Change-0.23 / -7.01%
  • Shares traded4.56m
  • 1 Year change-29.72%
  • Beta2.2865
Data delayed at least 15 minutes, as of Feb 12 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Butterfly Network, Inc. is a healthcare company focused on medical imaging with its Ultrasound-on-Chip semiconductor technology and ultrasound software solutions. The Company's solution, leveraging its Ultrasound-on-Chip technology, enables the practical application of ultrasound information into the clinical workflow. Its product portfolio includes a combination of hardware and software, including Butterfly iQ3, Butterfly iQ+, Butterfly iQ+ Bladder, and Butterfly iQ+ Vet devices, software subscriptions, and professional services. It offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials as well as its ScanLab education-only app, formal education programs through its Butterfly Academy software and Butterfly Certified courses, as well as professional services for large scale deployments. Its devices are commercially available to trained healthcare practitioners in areas including, but not limited to, parts of Africa, Asia, and Australia.

  • Revenue in USD (TTM)88.45m
  • Net income in USD-79.87m
  • Incorporated2020
  • Employees190.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Cytek Biosciences Inc196.83m-12.82m533.20m692.00--1.41--2.71-0.1011-0.10111.542.960.39921.863.60303,746.90-2.600.3407-3.020.381153.4658.12-6.510.86784.48--0.0213--3.8528.2050.44--30.83--
Pacific Biosciences of California Inc154.58m-503.63m555.51m575.00--15.39--3.59-1.69-1.690.52360.11960.13721.805.15268,841.80-44.70-16.31-47.29-17.7130.9534.48-325.80-156.405.40-19.940.947---23.1911.12-1.02--16.89--
Varex Imaging Corp854.40m-67.70m560.62m2.40k--1.18--0.6562-1.63-1.6319.3411.380.70321.856.00356,000.00-5.55-0.3327-6.45-0.395534.1533.16-7.89-0.46611.872.220.4321--4.142.73-47.38---0.5159--
Tactile Systems Technology Inc311.51m18.17m591.00m1.04k34.062.8823.731.900.77680.776813.289.181.148.388.07300,398.306.641.297.721.5549.8749.125.831.263.20--0.000.006.769.11-40.529.10-15.97--
Embecta Corp1.08bn139.50m592.20m1.85k4.23--3.270.54852.372.3718.31-10.350.97572.276.35583,621.6012.6116.6916.6022.6563.1766.7412.9215.711.873.181.7913.07-3.80-0.103321.84-25.93-26.03--
Beta Bionics Inc88.57m-77.84m596.53m404.00--2.02--6.74-2.07-2.072.216.700.41492.548.16304,364.30-36.46---40.57--54.51---87.89--9.83--0.00--442.93---24.17------
Alpha Tau Medical Ltd0.00-39.97m616.46m125.00--7.95-----0.5212-0.52120.000.90990.00----0.00-40.90-34.28-44.43-36.47------------0.0735-------8.89--11.60--
SI-Bone Inc193.58m-21.76m650.00m349.00--3.77--3.36-0.5113-0.51134.553.980.83931.297.53554,664.80-9.43-24.17-10.61-26.8779.6282.72-11.24-40.936.62--0.1711--20.3719.9628.67--33.83--
Bioventus Inc563.83m7.82m670.38m950.0072.114.0411.691.190.11230.11238.392.010.76661.954.47606,267.801.31-6.291.89-8.4967.7667.401.71-12.071.141.730.616--11.8911.0065.33---15.55--
Avanos Medical Inc699.90m-468.60m685.14m2.23k--0.8806--0.9789-10.18-10.1815.0916.760.51392.145.76314,279.30-34.41-4.82-39.66-5.4252.2854.01-66.95-11.321.368.920.1167--2.15-0.2826-3,802.02---18.86--
CeriBell Inc82.81m-52.46m739.69m281.00--4.50--8.93-1.45-1.452.294.430.67171.546.36294,708.20-42.55---48.06--87.99---63.35--12.25-29.420.1074--44.71---37.30------
Butterfly Network Inc88.45m-79.87m770.44m190.00--3.78--8.71-0.3347-0.33470.37290.80710.31860.74093.93465,515.80-28.77---34.57--43.24---90.31-190.033.56--0.00--24.52--45.78------
STAAR Surgical Co230.59m-96.37m820.24m1.16k--2.30--3.56-1.96-1.964.647.170.4641.292.80199,300.80-19.393.81-22.264.4273.8777.03-41.795.424.35--0.000.00-2.6415.89-194.66--18.11--
Integra Lifesciences Holdings Corp1.64bn-495.34m842.01m4.40k--0.8109--0.5125-6.46-6.4621.4513.330.42611.526.34373,741.10-12.852.90-15.393.2557.2162.59-30.157.141.802.680.63830.004.471.20-110.25---3.19--
Inmode Ltd370.50m93.83m906.03m660.009.911.339.582.451.441.445.6710.780.47741.199.28561,356.1012.0924.2113.3026.8278.5482.3625.3338.648.83--0.000.00-6.1612.44-48.244.5715.99--
Castle Biosciences Inc343.53m-12.24m931.12m761.00--1.9930.502.71-0.4533-0.453311.6716.020.63779.056.89451,419.20-2.27-6.95-2.50-7.5279.9480.76-3.56-17.496.31--0.0218--51.0944.97131.7543.5797.74--
Data as of Feb 12 2026. Currency figures normalised to Butterfly Network Inc's reporting currency: US Dollar USD

Institutional shareholders

31.08%Per cent of shares held by top holders
HolderShares% Held
Glenview Capital Management LLCas of 11 Dec 202519.25m8.51%
BlackRock Fund Advisorsas of 30 Sep 202512.66m5.60%
The Vanguard Group, Inc.as of 31 Dec 20259.86m4.36%
ARK Investment Management LLCas of 30 Sep 20256.15m2.72%
SSgA Funds Management, Inc.as of 30 Sep 20255.96m2.63%
Hood River Capital Management LLCas of 30 Sep 20255.41m2.39%
Geode Capital Management LLCas of 30 Sep 20254.60m2.04%
Citadel Securities LLCas of 30 Sep 20252.68m1.19%
UBS Securities LLCas of 31 Dec 20252.04m0.90%
Morgan Stanley & Co. LLCas of 30 Sep 20251.69m0.75%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.